These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Yousefipour G; Erfani N; Momtahan M; Moghaddasi H; Ghaderi A Acta Neurol Scand; 2009 Dec; 120(6):424-9. PubMed ID: 19737153 [TBL] [Abstract][Full Text] [Related]
3. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms at +49A/G and CT60 sites in the 3' UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism. Goswami R; Gupta N; Ray D; Rani R; Tomar N; Sarin R; Vupputuri MR Int J Immunogenet; 2005 Dec; 32(6):393-400. PubMed ID: 16313305 [TBL] [Abstract][Full Text] [Related]
5. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever. Gunesacar R; Erken E; Dinkci S Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220 [TBL] [Abstract][Full Text] [Related]
6. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease. Du L; Yang P; Hou S; Zhou H; Kijlstra A Br J Ophthalmol; 2009 Oct; 93(10):1378-81. PubMed ID: 19570770 [TBL] [Abstract][Full Text] [Related]
7. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients. Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188 [TBL] [Abstract][Full Text] [Related]
8. CTLA-4 +49 A/G gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Cizmarević NS; Gašparović I; Peterlin B; Sepčić J; Rudolf G; Kapović M; Lavtar P; Ristić S Int J Immunogenet; 2011 Oct; 38(5):419-26. PubMed ID: 21797987 [TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland. Greve B; Simonenko R; Illes Z; Peterfalvi A; Hamdi N; Mycko MP; Selmaj KW; Rozsa C; Rajczy K; Bauer P; Berger K; Weissert R Mult Scler; 2008 Mar; 14(2):153-8. PubMed ID: 17942509 [TBL] [Abstract][Full Text] [Related]
10. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region. Boćko D; Bilińska M; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Gruszka E; Frydecka I Arch Immunol Ther Exp (Warsz); 2003; 51(3):201-5. PubMed ID: 12894875 [TBL] [Abstract][Full Text] [Related]
11. CTLA4 and CD86 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Liu Y; Liang WB; Gao LB; Pan XM; Chen TY; Wang YY; Xue H; Zhang LS; Zhang L Hum Immunol; 2010 Nov; 71(11):1141-6. PubMed ID: 20732370 [TBL] [Abstract][Full Text] [Related]
12. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients. Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262 [TBL] [Abstract][Full Text] [Related]
14. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Umemura T; Ota M; Hamano H; Katsuyama Y; Muraki T; Arakura N; Kawa S; Kiyosawa K Am J Gastroenterol; 2008 Mar; 103(3):588-94. PubMed ID: 18341485 [TBL] [Abstract][Full Text] [Related]
15. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism. Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809 [TBL] [Abstract][Full Text] [Related]
16. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant. Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144 [TBL] [Abstract][Full Text] [Related]
17. Genomic regulation of CTLA4 and multiple sclerosis. Palacios R; Comas D; Elorza J; Villoslada P J Neuroimmunol; 2008 Oct; 203(1):108-15. PubMed ID: 18691768 [TBL] [Abstract][Full Text] [Related]
18. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population. Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005 [TBL] [Abstract][Full Text] [Related]
19. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Baniasadi V; Narain N; Goswami R; Das SN Tissue Antigens; 2006 May; 67(5):383-9. PubMed ID: 16671945 [TBL] [Abstract][Full Text] [Related]
20. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease. Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]